Christopher Surek, DO
Plastic Surgery · Cleveland, OHNPI 1114264637
Payments from drug & device makers
Across 621 payments — averaging $1649.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$638K
- AbbVie$366K
- Ipsen Innovation$12K
- Sientra, Inc.$4K
- Tepha Inc$1K
- Davol Inc.$525
- plus $3K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 291 | $638,188 |
| AbbVie(2 entities) | 211 | $365,596 |
| Ipsen Innovation | 4 | $12,325 |
| Sientra, Inc. | 70 | $4,059 |
| Tepha Inc | 9 | $1,340 |
| Davol Inc. | 5 | $525 |
| Motiva USA, LLC | 3 | $354 |
| Mentor Worldwide LLC | 4 | $318 |
| TELA Bio, Inc. | 2 | $291 |
| Bard Peripheral Vascular, Inc. | 1 | $241 |
| Lilly USA, LLC | 2 | $184 |
| Integra Lifesciences Corporation | 3 | $175 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $139 |
| Sun Pharmaceutical Industries Inc. | 1 | $122 |
| Pfizer | 1 | $112 |
| Bristol Myers Squibb | 1 | $111 |
| Stemline Therapeutics Inc. | 1 | $105 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Merz North America, Inc. | 1 | $76 |
| E.r. Squibb & Sons, L.L.C. | 1 | $68 |
| Baudax Bio Inc. | 1 | $32 |
| Almirall LLC | 2 | $28 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Arteriocyte Medical Systems, Inc. | 1 | $14 |
How this compares
$1,024,535 in reported general payments places this provider in the 95th percentile of 191 plastic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery in Cleveland
- Brian GastmanCleveland$4.8M
- Risal DjohanCleveland$848K
- Maria SiemionowCleveland$267K
- Anthony TufaroCleveland$56K
- Sarah BishopCleveland$24K
- Rachel AliottaCleveland$14K
- Meenakshi RajanCleveland$14K
- Donald HarveyCleveland$9K
- Jacob GrowCleveland$8K
- Raymond IsakovCleveland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.